Cargando…
Strontium ranelate enriched Ruminococcus albus in the gut microbiome of Sprague–Dawley rats with postmenopausal osteoporosis
BACKGROUND: Gut microbiome is critical to our human health and is related to postmenopausal osteoporosis (PMO). Strontium ranelate (SrR) is an anti-osteoporosis oral drug that can promote osteoblast formation and inhibit osteoclast formation. However, the effect of SrR on gut microbiome has been rar...
Autores principales: | Xiao, Xiao, Cui, Yuanyuan, Lu, Huigai, Wang, Jiaqi, Yang, Jing, Liu, Long, Liu, Zhixin, Peng, Xiaohong, Cao, Hong, Liu, Xinghui, Wei, Xiuli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10680188/ https://www.ncbi.nlm.nih.gov/pubmed/38008735 http://dx.doi.org/10.1186/s12866-023-03109-z |
Ejemplares similares
-
Strontium ranelate in postmenopausal osteoporosis treatment: a critical appraisal
por: Cesareo, Roberto, et al.
Publicado: (2010) -
Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis
por: Reginster, J-Y., et al.
Publicado: (2011) -
Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis
por: Roux, C, et al.
Publicado: (2008) -
Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacy
por: Blake, Glen M, et al.
Publicado: (2006) -
Efficacy of Strontium Ranelate in Combination with a D-Hormone Analog for the Treatment of Postmenopausal Osteoporosis
por: Abboskhujaeva, Lola S., et al.
Publicado: (2014)